| Dr Christine Madeleine Mccarty, MD | |
|
301 S 7th Ave, Suite 1120, West Reading, PA 19611-1410 | |
| (484) 628-0580 | |
| (610) 374-1902 |
| Full Name | Dr Christine Madeleine Mccarty |
|---|---|
| Gender | Female |
| Speciality | Thoracic Surgery |
| Experience | 40 Years |
| Location | 301 S 7th Ave, West Reading, Pennsylvania |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1972561181 | NPI | - | NPPES |
| 001286575 | Medicaid | PA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208G00000X | Thoracic Surgery (cardiothoracic Vascular Surgery) | MD035325E (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Chester County Hospital | West chester, PA | Hospital |
| Robert Packer Hospital | Sayre, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Guthrie Medical Group Pc | 6002728656 | 612 |
| University Of Penn - Medical Group | 6204730955 | 3031 |
News Archive
The number of cases of progressive massive fibrosis (PMF) among U.S. coal miners has risen during the past two decades, even as the number of coal miners has declined, according to new research published online in the Annals of the American Thoracic Society.
In the current issue of Psychotherapy and Psychosomaticsthere is news about an international group of investigators who felt that benzodiazepines are getting unwarranted bad press, compared to other psychotropic drugs.
In the evolving global healthcare marketplace, a patient-centric approach has become part of the formula for long-term success in the pharmaceutical sector. Facing declining sales from patent losses and payer pressures, the pharma sector is turning to patient support programs and activities to help drive clinical and commercial success.
Galderma Laboratories, L.P. announced that the U.S. Food and Drug Administration has approved Mirvaso (brimonidine) topical gel, 0.33% for the topical treatment of the facial erythema (redness) of rosacea in adults 18 years of age or older. Applied once daily, Mirvaso works quickly to reduce the redness of rosacea and lasts up to 12 hours. Galderma expects Mirvaso to be available in pharmacies September 2013.
Researchers say that oral anticoagulation could improve the prognosis of atrial fibrillation patients who undergo percutaneous coronary intervention, even if they have a high bleeding risk according to the HAS-BLED score.
› Verified 5 days ago
| Entity Name | Guthrie Medical Group Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1962451153 PECOS PAC ID: 6002728656 Enrollment ID: O20040301000571 |
News Archive
The number of cases of progressive massive fibrosis (PMF) among U.S. coal miners has risen during the past two decades, even as the number of coal miners has declined, according to new research published online in the Annals of the American Thoracic Society.
In the current issue of Psychotherapy and Psychosomaticsthere is news about an international group of investigators who felt that benzodiazepines are getting unwarranted bad press, compared to other psychotropic drugs.
In the evolving global healthcare marketplace, a patient-centric approach has become part of the formula for long-term success in the pharmaceutical sector. Facing declining sales from patent losses and payer pressures, the pharma sector is turning to patient support programs and activities to help drive clinical and commercial success.
Galderma Laboratories, L.P. announced that the U.S. Food and Drug Administration has approved Mirvaso (brimonidine) topical gel, 0.33% for the topical treatment of the facial erythema (redness) of rosacea in adults 18 years of age or older. Applied once daily, Mirvaso works quickly to reduce the redness of rosacea and lasts up to 12 hours. Galderma expects Mirvaso to be available in pharmacies September 2013.
Researchers say that oral anticoagulation could improve the prognosis of atrial fibrillation patients who undergo percutaneous coronary intervention, even if they have a high bleeding risk according to the HAS-BLED score.
› Verified 5 days ago
| Entity Name | Tower Health Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1609291350 PECOS PAC ID: 7618889213 Enrollment ID: O20040311000072 |
News Archive
The number of cases of progressive massive fibrosis (PMF) among U.S. coal miners has risen during the past two decades, even as the number of coal miners has declined, according to new research published online in the Annals of the American Thoracic Society.
In the current issue of Psychotherapy and Psychosomaticsthere is news about an international group of investigators who felt that benzodiazepines are getting unwarranted bad press, compared to other psychotropic drugs.
In the evolving global healthcare marketplace, a patient-centric approach has become part of the formula for long-term success in the pharmaceutical sector. Facing declining sales from patent losses and payer pressures, the pharma sector is turning to patient support programs and activities to help drive clinical and commercial success.
Galderma Laboratories, L.P. announced that the U.S. Food and Drug Administration has approved Mirvaso (brimonidine) topical gel, 0.33% for the topical treatment of the facial erythema (redness) of rosacea in adults 18 years of age or older. Applied once daily, Mirvaso works quickly to reduce the redness of rosacea and lasts up to 12 hours. Galderma expects Mirvaso to be available in pharmacies September 2013.
Researchers say that oral anticoagulation could improve the prognosis of atrial fibrillation patients who undergo percutaneous coronary intervention, even if they have a high bleeding risk according to the HAS-BLED score.
› Verified 5 days ago
| Entity Name | Phoenixville Clinic Company Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1891866182 PECOS PAC ID: 5799796850 Enrollment ID: O20060606000128 |
News Archive
The number of cases of progressive massive fibrosis (PMF) among U.S. coal miners has risen during the past two decades, even as the number of coal miners has declined, according to new research published online in the Annals of the American Thoracic Society.
In the current issue of Psychotherapy and Psychosomaticsthere is news about an international group of investigators who felt that benzodiazepines are getting unwarranted bad press, compared to other psychotropic drugs.
In the evolving global healthcare marketplace, a patient-centric approach has become part of the formula for long-term success in the pharmaceutical sector. Facing declining sales from patent losses and payer pressures, the pharma sector is turning to patient support programs and activities to help drive clinical and commercial success.
Galderma Laboratories, L.P. announced that the U.S. Food and Drug Administration has approved Mirvaso (brimonidine) topical gel, 0.33% for the topical treatment of the facial erythema (redness) of rosacea in adults 18 years of age or older. Applied once daily, Mirvaso works quickly to reduce the redness of rosacea and lasts up to 12 hours. Galderma expects Mirvaso to be available in pharmacies September 2013.
Researchers say that oral anticoagulation could improve the prognosis of atrial fibrillation patients who undergo percutaneous coronary intervention, even if they have a high bleeding risk according to the HAS-BLED score.
› Verified 5 days ago
| Entity Name | University Of Penn - Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235527342 PECOS PAC ID: 6204730955 Enrollment ID: O20141111000091 |
News Archive
The number of cases of progressive massive fibrosis (PMF) among U.S. coal miners has risen during the past two decades, even as the number of coal miners has declined, according to new research published online in the Annals of the American Thoracic Society.
In the current issue of Psychotherapy and Psychosomaticsthere is news about an international group of investigators who felt that benzodiazepines are getting unwarranted bad press, compared to other psychotropic drugs.
In the evolving global healthcare marketplace, a patient-centric approach has become part of the formula for long-term success in the pharmaceutical sector. Facing declining sales from patent losses and payer pressures, the pharma sector is turning to patient support programs and activities to help drive clinical and commercial success.
Galderma Laboratories, L.P. announced that the U.S. Food and Drug Administration has approved Mirvaso (brimonidine) topical gel, 0.33% for the topical treatment of the facial erythema (redness) of rosacea in adults 18 years of age or older. Applied once daily, Mirvaso works quickly to reduce the redness of rosacea and lasts up to 12 hours. Galderma expects Mirvaso to be available in pharmacies September 2013.
Researchers say that oral anticoagulation could improve the prognosis of atrial fibrillation patients who undergo percutaneous coronary intervention, even if they have a high bleeding risk according to the HAS-BLED score.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Christine Madeleine Mccarty, MD Po Box 13579, Reading, PA 19612-3579 Ph: () - | Dr Christine Madeleine Mccarty, MD 301 S 7th Ave, Suite 1120, West Reading, PA 19611-1410 Ph: (484) 628-0580 |
News Archive
The number of cases of progressive massive fibrosis (PMF) among U.S. coal miners has risen during the past two decades, even as the number of coal miners has declined, according to new research published online in the Annals of the American Thoracic Society.
In the current issue of Psychotherapy and Psychosomaticsthere is news about an international group of investigators who felt that benzodiazepines are getting unwarranted bad press, compared to other psychotropic drugs.
In the evolving global healthcare marketplace, a patient-centric approach has become part of the formula for long-term success in the pharmaceutical sector. Facing declining sales from patent losses and payer pressures, the pharma sector is turning to patient support programs and activities to help drive clinical and commercial success.
Galderma Laboratories, L.P. announced that the U.S. Food and Drug Administration has approved Mirvaso (brimonidine) topical gel, 0.33% for the topical treatment of the facial erythema (redness) of rosacea in adults 18 years of age or older. Applied once daily, Mirvaso works quickly to reduce the redness of rosacea and lasts up to 12 hours. Galderma expects Mirvaso to be available in pharmacies September 2013.
Researchers say that oral anticoagulation could improve the prognosis of atrial fibrillation patients who undergo percutaneous coronary intervention, even if they have a high bleeding risk according to the HAS-BLED score.
› Verified 5 days ago
Dr. Ron D. Nutting, M.D. Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Not Enrolled in Medicare Practice Location: 301 S 7th Ave, Ste 1120, West Reading, PA 19611 Phone: 610-374-5000 Fax: 610-988-4242 | |
Rohinton J Morris, M.D. Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Accepting Medicare Assignments Practice Location: 301 S 7th Ave Ste 1120, West Reading, PA 19611 Phone: 484-628-0580 | |
Uday K. Dasika, M.D. Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Accepting Medicare Assignments Practice Location: 301 S 7th Ave, Suite 1120, West Reading, PA 19611 Phone: 484-628-0580 Fax: 610-374-1902 | |
Ronald Howard Figura, M.D. Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Accepting Medicare Assignments Practice Location: 301 S 7th Ave Ste 1120, West Reading, PA 19611 Phone: 484-628-0580 Fax: 610-374-1902 | |
Dr. Marshall M. Feaster, M.D. Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Not Enrolled in Medicare Practice Location: 301 S 7th Ave, Ste 1120, West Reading, PA 19611 Phone: 610-374-5000 Fax: 610-988-4242 |